Curis
CRIS
#10277
Rank
S$30.13 M
Marketcap
S$0.75
Share price
-1.33%
Change (1 day)
-76.55%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): S-$4.87

According to Curis's latest financial reports the company's current EPS (TTM) is S-$4.67. In 2024 the company made an earnings per share (EPS) of S-$8.95 an increase over its 2023 EPS that were of S-$11.50.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.87-45.54%
2024S-$8.95-22.15%
2023S-$11.50-26.17%
2022S-$15.5722.3%
2021S-$12.73-25.37%
2020S-$17.06-30.93%
2019S-$24.70-2.02%
2018S-$25.21
2016S-$57.30-10%
2015S-$63.67138.1%
2014S-$26.7440%
2013S-$19.10-25%
2012S-$25.4766.67%
2011S-$15.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.73-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.41-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$3.68-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$4.95 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$14.31 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.80-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA